• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Pediatric Studies Characteristics - Detail

  • Print
  • Share
  • E-mail
-
 
Approval Date:  05/17/2012
 
Trade Name:  Pertzye
 
Generic or Proper Name (*):  pancrelipase
 
Indications Studied:  Treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions
 
Therapeutic Category:  Pancreatic enzyme
 
Ages Studied:  1-17 years
 
Study #:  7
 
Study Type:  Efficacy/Safety
 
Study Design:  Blind/Active Control/Crossover
 
No Patients:  12
 
No Centers:  1
 
No Countries:  1
 
BPCA(B), PREA(P):  P
 
Asian:  0
 
-
-